6-50823451-G-C

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_003221.4(TFAP2B):ā€‹c.126G>Cā€‹(p.Gln42His) variant causes a missense change. The variant allele was found at a frequency of 0.0000435 in 1,609,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000053 ( 0 hom., cov: 31)
Exomes š‘“: 0.000043 ( 0 hom. )

Consequence

TFAP2B
NM_003221.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.79
Variant links:
Genes affected
TFAP2B (HGNC:11743): (transcription factor AP-2 beta) This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17997324).
BS2
High AC in GnomAd4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TFAP2BNM_003221.4 linkuse as main transcriptc.126G>C p.Gln42His missense_variant 2/7 ENST00000393655.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TFAP2BENST00000393655.4 linkuse as main transcriptc.126G>C p.Gln42His missense_variant 2/71 NM_003221.4 P1Q92481-1
TFAP2BENST00000344788.7 linkuse as main transcriptc.120G>C p.Gln40His missense_variant 3/43
TFAP2BENST00000489228.1 linkuse as main transcriptn.421G>C non_coding_transcript_exon_variant 2/22

Frequencies

GnomAD3 genomes
AF:
0.0000527
AC:
8
AN:
151822
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000847
AC:
2
AN:
236146
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
128524
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000190
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000425
AC:
62
AN:
1457332
Hom.:
0
Cov.:
33
AF XY:
0.0000442
AC XY:
32
AN XY:
724656
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000522
Gnomad4 OTH exome
AF:
0.0000665
GnomAD4 genome
AF:
0.0000527
AC:
8
AN:
151822
Hom.:
0
Cov.:
31
AF XY:
0.0000540
AC XY:
4
AN XY:
74128
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000564
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.00000825
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 15, 2023The c.126G>C (p.Q42H) alteration is located in exon 2 (coding exon 2) of the TFAP2B gene. This alteration results from a G to C substitution at nucleotide position 126, causing the glutamine (Q) at amino acid position 42 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Benign
-0.026
T
BayesDel_noAF
Benign
-0.26
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.33
.;T
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.071
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.92
D;D
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.18
T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
1.1
.;L
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.24
Sift
Benign
0.47
T;T
Sift4G
Benign
0.66
T;T
Polyphen
0.0010
.;B
Vest4
0.60
MutPred
0.17
.;Gain of glycosylation at S41 (P = 0.1534);
MVP
0.51
MPC
1.0
ClinPred
0.58
D
GERP RS
3.5
Varity_R
0.13
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs776835953; hg19: chr6-50791164; API